Azelaic Acid (Finacea Foam, BAY39-6251)
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
20
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Rosacea
Conditions
Rosacea
Trial Timeline
Jul 20, 2017 → Nov 15, 2017
NCT ID
NCT03193372About Azelaic Acid (Finacea Foam, BAY39-6251)
Azelaic Acid (Finacea Foam, BAY39-6251) is a pre-clinical stage product being developed by Bayer for Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT03193372. Target conditions include Rosacea.
Hype Score Breakdown
Clinical
5
Activity
2
Company
7
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03193372 | Pre-clinical | Completed |
Competing Products
20 competing products in Rosacea